These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1298 related items for PubMed ID: 26832880

  • 21. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
    McNally L, Teng NN, Kapp DS, Karam A.
    Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
    [Abstract] [Full Text] [Related]

  • 22. Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
    Risum S, Loft A, Engelholm SA, Høgdall E, Berthelsen AK, Nedergaard L, Lundvall L, Høgdall C.
    Int J Gynecol Cancer; 2012 Sep; 22(7):1163-9. PubMed ID: 22810969
    [Abstract] [Full Text] [Related]

  • 23. Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer.
    Ren Y, Shi T, Jiang R, Yin S, Wang P, Zang R.
    Int J Gynecol Cancer; 2015 Oct; 25(8):1398-404. PubMed ID: 26222486
    [Abstract] [Full Text] [Related]

  • 24. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
    Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ.
    Int J Gynecol Cancer; 2003 Oct; 13(5):664-72. PubMed ID: 14675352
    [Abstract] [Full Text] [Related]

  • 25. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 26. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K.
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [Abstract] [Full Text] [Related]

  • 27. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD, Lee JC, Metzger DJ, Ashamalla H, Katsoulakis E.
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients.
    Fournier M, Stoeckle E, Guyon F, Brouste V, Thomas L, MacGrogan G, Floquet A.
    Int J Gynecol Cancer; 2009 Nov; 19(8):1307-13. PubMed ID: 20009882
    [Abstract] [Full Text] [Related]

  • 30. Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.
    Raspagliesi F, Bogani G, Ditto A, Martinelli F, Chiappa V, Borghi C, Scaffa C, Morano F, Maltese G, Lorusso D.
    Ann Surg Oncol; 2017 Oct; 24(11):3396-3405. PubMed ID: 28795373
    [Abstract] [Full Text] [Related]

  • 31. Survival Rates between Early Stage Endometrial Carcinoma With or Without Para-Aortic Lymph Node Resection.
    Thanagumtorn K.
    J Med Assoc Thai; 2016 Sep; 99(9):975-81. PubMed ID: 29927197
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F, Meinhold-Heerlein I.
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [Abstract] [Full Text] [Related]

  • 34. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N, Zafrani Y, Uzan C, Gouy S, Rey A, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P.
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [Abstract] [Full Text] [Related]

  • 35. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
    Bacalbasa N, Dima S, Brasoveanu V, David L, Balescu I, Purnichescu-Purtan R, Popescu I.
    World J Surg Oncol; 2015 Aug 05; 13():235. PubMed ID: 26243426
    [Abstract] [Full Text] [Related]

  • 36. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N.
    Int J Gynecol Cancer; 2015 Jan 05; 25(1):81-6. PubMed ID: 25347094
    [Abstract] [Full Text] [Related]

  • 37. Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer.
    Derlatka P, Sienko J, Grabowska-Derlatka L, Palczewski P, Danska-Bidzinska A, Bidzinski M, Czajkowski K.
    World J Surg Oncol; 2016 Feb 29; 14():58. PubMed ID: 26923029
    [Abstract] [Full Text] [Related]

  • 38. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S.
    Int J Gynecol Cancer; 2013 Jun 29; 23(5):839-45. PubMed ID: 23694981
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
    Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E.
    Int J Gynecol Cancer; 2013 Mar 29; 23(3):461-8. PubMed ID: 23370604
    [Abstract] [Full Text] [Related]

  • 40. Outcome of Epithelial Ovarian Cancer: Time for Strategy Trials to Resolve the Problem of Optimal Timing of Surgery.
    Van de Putte G, Oben J, Prenen L, Schobbens JC, Vlasselaer J, Van Holsbeke C, Debrock G, Van Eycken P, de Jonge E.
    Int J Gynecol Cancer; 2015 Jul 29; 25(6):993-9. PubMed ID: 25914962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.